巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

Gilead Sciences

GILD
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・Gilead Sciences - 延遲價格・最後更新於 14/01 12:14
最高位
72.140
最低位
71.170
開市價
--
前收市價
71.900
成交量(千)
809.77
成交額(百萬)
386.43
買入
--
賣出
--
每手股數
--
市值(百萬)
90,014.56
市盈率
12.220
息率
3.96%
差價
--
52週高低
74.120 - 57.929
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
Gilead Sciences
證券代碼
GILD.US
所屬板塊
Drug Manufacturers - General
公司業務
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
發行量
1254383522
公司總部
333 Lakeside Drive
公司網址
https://www.gilead.com
公司電郵
investor_relations@gilead.com
公司電話
+1 650 574-3000

吉利德科學(GILD.US)盤前漲超1% 公司稱瑞德西韋對所有已知的變異株都起作用

格隆匯··精選
吉利德科學(GILD.US)盤前漲超1% 公司稱瑞德西韋對所有已知的變異株都起作用

格隆匯12月3日丨據吉利德科學微信公眾號

格隆匯··精選
格隆匯12月3日丨據吉利德科學微信公眾號

關於

Gilead Sciences(GILD.US)所屬的行業板塊為Drug Manufacturers - General。
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.
截至14/01 12:14:59,Gilead Sciences的股價跌-0.19,市值90,014.56百萬。Gilead Sciences的市盈率及息率分別為12.220及3.96%。
詳細公司背景可參考: https://www.gilead.com